Which scale best measures the effectiveness of anticholinergic therapy?

Which scale best measures the effectiveness of anticholinergic therapy?

• A. DRDT-Daily Record of Dysfunctional Thoughts.
• B. IADL-Instrumental Activities of Daily Living.
• C. VAS-Visual Analog Scale.
• D. AIMS-Abnormal Involuntary Movement Scale.

Answer: (D)

The main idea is tracking movement side effects caused by antipsychotic treatment. AIMS is a focused, standardized scale that rates abnormal involuntary movements across multiple body regions (face, tongue, limbs, trunk). When anticholinergic therapy is given to counteract extrapyramidal symptoms, changes in these involuntary movements are best captured by the AIMS score. A decrease in the AIMS score after treatment indicates improvement, making this scale the most relevant tool for assessing how well the therapy is working. The other scales measure different domains—cognition/thought content, daily living activities, or subjective intensity of symptoms—so they don’t specifically reflect movement changes targeted by anticholinergic therapy.

The main idea is tracking movement side effects caused by antipsychotic treatment. AIMS is a focused, standardized scale that rates abnormal involuntary movements across multiple body regions (face, tongue, limbs, trunk). When anticholinergic therapy is given to counteract extrapyramidal symptoms, changes in these involuntary movements are best captured by the AIMS score. A decrease in the AIMS score after treatment indicates improvement, making this scale the most relevant tool for assessing how well the therapy is working. The other scales measure different domains—cognition/thought content, daily living activities, or subjective intensity of symptoms—so they don’t specifically reflect movement changes targeted by anticholinergic therapy.